Omnicare (OCR) is staging a nice rebound after seeing to recent lows. Analysts are upbeat on the company, boosting full-year forecasts from $2.41 per share to $2.56 over the past 3 months. < ?DART(15);?>

Company Description

Omnicare, Inc. provides pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities and other chronic care settings comprising beds in fourteen states, the District of Columbia and Canada.

Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings.

Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in thirty countries worldwide

Robust Results

The company recently announced fourth-quarter adjusted earnings of 66 cents per share, exceeding the consensus estimate by 5%

...

Omnicare, Inc. (...